These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23067670)

  • 21. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease.
    Borlongan CV; Koutouzis TK; Poulos SG; Saporta S; Sanberg PR
    Cell Transplant; 1998; 7(2):131-5. PubMed ID: 9588595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
    Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
    Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus.
    Ayalon L; Doron R; Weiner I; Joel D
    Exp Neurol; 2004 Mar; 186(1):46-58. PubMed ID: 14980809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
    Araujo DM; Hilt DC
    Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant self-grooming as early marker of motor dysfunction in a rat model of Huntington's disease.
    Tartaglione AM; Armida M; Potenza RL; Pezzola A; Popoli P; Calamandrei G
    Behav Brain Res; 2016 Oct; 313():53-57. PubMed ID: 27374158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease.
    Zhu M; Shu K; Wang H; Li X; Xiao Q; Chan W; Emmanuel B; Jiang W; Lei T
    J Neurosci Res; 2013 Dec; 91(12):1563-71. PubMed ID: 24105649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal grafts in a rat model of Huntington's disease: time course comparison of MRI and histology.
    Guzman R; Meyer M; Lövblad KO; Ozdoba C; Schroth G; Seiler RW; Widmer HR
    Exp Neurol; 1999 Mar; 156(1):180-90. PubMed ID: 10192789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
    Verma MK; Goel R; Nandakumar K; Nemmani KVS
    Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease.
    McLeod MC; Kobayashi NR; Sen A; Baghbaderani BA; Sadi D; Ulalia R; Behie LA; Mendez I
    Cell Transplant; 2013; 22(12):2237-56. PubMed ID: 23127784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats.
    Klein A; Metz GA; Papazoglou A; Nikkhah G
    Neurobiol Dis; 2007 Jul; 27(1):24-35. PubMed ID: 17512748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor training effects on recovery of function after striatal lesions and striatal grafts.
    Döbrössy MD; Dunnett SB
    Exp Neurol; 2003 Nov; 184(1):274-84. PubMed ID: 14637098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model.
    Nikkhah G; Duan WM; Knappe U; Jödicke A; Björklund A
    Neuroscience; 1993 Sep; 56(1):33-43. PubMed ID: 8232915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
    McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
    J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
    Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Popoli P; Pezzola A; Reggio R; Calamandrei G
    Behav Brain Res; 2004 Jul; 152(2):375-83. PubMed ID: 15196806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in rats.
    Popoli P; Pèzzola A; Domenici MR; Sagratella S; Diana G; Caporali MG; Bronzetti E; Vega J; Scotti de Carolis A
    Brain Res Bull; 1994; 35(4):329-35. PubMed ID: 7850482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease.
    Watts C; Brasted PJ; Dunnett SB
    Exp Neurol; 2000 May; 163(1):85-97. PubMed ID: 10785447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.